Acuren [TIC] vs Copart [CPRT] Detailed Stock Comparison

Acuren

Copart
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Acuren wins in 5 metrics, Copart wins in 12 metrics, with 0 ties. Copart appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Acuren | Copart | Better |
---|---|---|---|
P/E Ratio (TTM) | 44.48 | 28.37 | Copart |
Price-to-Book Ratio | 1.47 | 4.75 | Acuren |
Debt-to-Equity Ratio | 68.97 | 1.13 | Copart |
PEG Ratio | N/A | 1.38 | N/A |
EV/EBITDA | 42.78 | 42.24 | Copart |
Profit Margin (TTM) | -12.62% | 33.41% | Copart |
Operating Margin (TTM) | 6.01% | 36.78% | Copart |
EBITDA Margin (TTM) | 6.01% | 36.78% | Copart |
Return on Equity | -18.02% | 18.48% | Copart |
Return on Assets (TTM) | -1.05% | 11.84% | Copart |
Free Cash Flow (TTM) | $73.67M | $1.23B | Copart |
1-Year Return | 12.54% | -14.73% | Acuren |
Price-to-Sales Ratio (TTM) | 2.56 | 9.39 | Acuren |
Enterprise Value | $3.54B | $82.64B | Copart |
EV/Revenue Ratio | 3.18 | 17.79 | Acuren |
Gross Profit Margin (TTM) | 23.60% | 45.30% | Copart |
Revenue per Share (TTM) | $10 | $5 | Acuren |
Earnings per Share (Diluted) | $-1.25 | $1.59 | Copart |
Beta (Stock Volatility) | N/A | 1.03 | N/A |
Acuren vs Copart Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Acuren | -0.21% | -2.14% | 26.27% | 25.04% | 40.54% | 18.17% |
Copart | 1.21% | 0.53% | -6.26% | -8.54% | -20.36% | -19.90% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Acuren | 12.54% | 12.54% | 415.64% | -99.89% | -99.82% | -99.82% |
Copart | -14.73% | 64.51% | 56.63% | 937.01% | 2,017.84% | 2,947.97% |
News Based Sentiment: Acuren vs Copart
Acuren
News based Sentiment: MIXED
October brought a major rebranding for Acuren as it became TIC Solutions following the NV5 merger, but this was tempered by disappointing preliminary Q3 results. The mixed signals – a positive strategic shift alongside weaker financials – create a complex investment picture, making this a significant month for the company.
Copart
News based Sentiment: MIXED
Copart delivered a solid Q3 earnings report with revenue growth, but the mixed analyst sentiment, insider selling, and a Zacks downgrade create a complex investment picture. The company's strategic investments and global expansion are positive, but require further monitoring to assess their impact.
Performance & Financial Health Analysis: Acuren vs Copart
Metric | TIC | CPRT |
---|---|---|
Market Information | ||
Market Cap | $3.01B | $44.10B |
Market Cap Category | Mid cap | Large cap |
10 Day Avg. Volume | 3,916,990 | 6,856,740 |
90 Day Avg. Volume | 3,411,450 | 7,689,460 |
Last Close | $14.18 | $45.11 |
52 Week Range | $8.76 - $14.94 | $44.23 - $64.38 |
% from 52W High | -5.11% | -29.93% |
All-Time High | $14,700.00 (Jul 03, 2017) | $64.38 (Nov 25, 2024) |
% from All-Time High | -99.90% | -29.93% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.02% | 0.05% |
Quarterly Earnings Growth | N/A | 0.23% |
Financial Health | ||
Profit Margin (TTM) | -0.13% | 0.33% |
Operating Margin (TTM) | 0.06% | 0.37% |
Return on Equity (TTM) | -0.18% | 0.18% |
Debt to Equity (MRQ) | 68.97 | 1.13 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $9.63 | $9.50 |
Cash per Share (MRQ) | $0.65 | $2.47 |
Operating Cash Flow (TTM) | $58.13M | $1.80B |
Levered Free Cash Flow (TTM) | $127.12M | $869.61M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Acuren vs Copart
Metric | TIC | CPRT |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 44.48 | 28.37 |
Forward P/E | 31.84 | 25.93 |
PEG Ratio | N/A | 1.38 |
Price to Sales (TTM) | 2.56 | 9.39 |
Price to Book (MRQ) | 1.47 | 4.75 |
Market Capitalization | ||
Market Capitalization | $3.01B | $44.10B |
Enterprise Value | $3.54B | $82.64B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.18 | 17.79 |
Enterprise to EBITDA | 42.78 | 42.24 |
Risk & Other Metrics | ||
Beta | N/A | 1.03 |
Book Value per Share (MRQ) | $9.63 | $9.50 |
Financial Statements Comparison: Acuren vs Copart
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | TIC | CPRT |
---|---|---|
Revenue/Sales | $234.22M | $1.13B |
Cost of Goods Sold | $190.55M | $615.38M |
Gross Profit | $43.67M | $509.72M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $-8.79M | $412.59M |
EBITDA | $20.93M | $466.73M |
Pre-Tax Income | $-24.33M | $478.41M |
Income Tax | $1.47M | $83.10M |
Net Income (Profit) | $-25.79M | $395.31M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | TIC | CPRT |
---|---|---|
Cash & Equivalents | $155.74M | $2.78B |
Total Current Assets | $376.67M | $5.75B |
Total Current Liabilities | $107.93M | $683.28M |
Long-Term Debt | $784.25M | $83.87M |
Total Shareholders Equity | $1.13B | $9.21B |
Retained Earnings | $-132.78M | $8.09B |
Property, Plant & Equipment | $30.52M | $99.71M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | TIC | CPRT |
---|---|---|
Operating Cash Flow | $35.09M | $432.33M |
Capital Expenditures | $-4.18M | $-60.34M |
Free Cash Flow | $28.32M | $350.84M |
Debt Repayment | $-4.44M | $-5,000 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | TIC | CPRT |
---|---|---|
Shares Short | 7.41M | 26.27M |
Short Ratio | 4.29 | 3.89 |
Short % of Float | 0.06% | 0.03% |
Average Daily Volume (10 Day) | 3,916,990 | 6,856,740 |
Average Daily Volume (90 Day) | 3,411,450 | 7,689,460 |
Shares Outstanding | 121.48M | 967.48M |
Float Shares | 138.35M | 1.78B |
% Held by Insiders | 0.10% | 0.09% |
% Held by Institutions | 0.55% | 0.87% |
Dividend Analysis & Yield Comparison: Acuren vs Copart
Metric | TIC | CPRT |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |